EMCL-REGISTRY
MCL is a rare disease and for various reasons not every question can be addressed in a
clinical trial. Registry data can help to evaluate open questions by collecting real world information about treatments and disease courses. At this time the registry focusses on patients considered to suffer from so called indolent MCL or patients with relapsed disease receiving second line treatment with a novel targeted agent.